This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.
Print Page  |  Contact Us  |  Report Abuse  |  Sign In  |  Register
News & Press: General News

Akcea's Novel Drug Cuts Lipoprotein(a)

Friday, September 13, 2013  
Posted by: Sandra Tremulis
Share |

Lipoprotein(a) is an emerging risk factor for cardiovascular disease, but there are limited options for lowering elevated levels.AMG145, a fully human monoclonal antibody to a protein synthesized and secreted by the hepatocyte, that binds to the low-density lipoprotein (LDL) receptor, significantly reduced Lp(a) among subjects with hypercholesterolemia receiving statin therapy.

Community Search
Sign In
Login with LinkedIn

Latest News
809 Laurel Street #460
San Carlos, CA 94070